| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16,279 |
14,399 |
$1.43M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,564 |
13,788 |
$1.41M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,868 |
13,676 |
$1.31M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,721 |
1,736 |
$401K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,391 |
781 |
$337K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,527 |
1,416 |
$281K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,652 |
5,886 |
$259K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,978 |
1,048 |
$212K |
| 70450 |
Computed tomography, head or brain; without contrast material |
827 |
662 |
$170K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
637 |
479 |
$157K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
561 |
413 |
$131K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,344 |
2,217 |
$117K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,005 |
550 |
$116K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,094 |
761 |
$96K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
401 |
276 |
$86K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,783 |
1,640 |
$84K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,202 |
1,027 |
$72K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,906 |
516 |
$70K |
| G0378 |
Hospital observation service, per hour |
1,064 |
583 |
$65K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,845 |
3,090 |
$64K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
582 |
306 |
$60K |
| 87631 |
|
426 |
303 |
$57K |
| 80053 |
Comprehensive metabolic panel |
6,791 |
5,400 |
$49K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
6,875 |
5,501 |
$37K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
208 |
99 |
$36K |
| A0425 |
Ground mileage, per statute mile |
747 |
628 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,978 |
9,434 |
$27K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
388 |
325 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
988 |
815 |
$25K |
| 29581 |
|
304 |
103 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
18,390 |
13,687 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,572 |
1,284 |
$22K |
| 97161 |
|
542 |
461 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,214 |
1,633 |
$18K |
| 80061 |
Lipid panel |
1,068 |
917 |
$15K |
| 87070 |
|
1,002 |
774 |
$14K |
| 84439 |
|
863 |
704 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
874 |
758 |
$11K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
138 |
62 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
558 |
522 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,202 |
954 |
$10K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
40 |
25 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,273 |
2,454 |
$9K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
146 |
112 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,865 |
1,423 |
$9K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
426 |
367 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
280 |
230 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
385 |
341 |
$8K |
| 99222 |
Initial hospital care, per day, moderate complexity |
306 |
263 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
298 |
242 |
$7K |
| 64493 |
|
14 |
13 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
2,437 |
1,914 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
28 |
15 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
420 |
283 |
$4K |
| 80305 |
|
587 |
459 |
$4K |
| 87077 |
|
736 |
575 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
655 |
485 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
32 |
28 |
$3K |
| 0012A |
|
114 |
92 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
81 |
76 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
216 |
196 |
$3K |
| 81003 |
|
3,285 |
2,610 |
$3K |
| 84484 |
|
2,016 |
1,373 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
19 |
15 |
$3K |
| 81001 |
|
1,403 |
1,130 |
$3K |
| 86803 |
|
97 |
87 |
$3K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
207 |
101 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,809 |
1,117 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
147 |
135 |
$2K |
| 0011A |
|
84 |
73 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
19 |
13 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,776 |
2,104 |
$2K |
| 82570 |
|
323 |
257 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34 |
30 |
$2K |
| 87186 |
|
623 |
494 |
$2K |
| 59025 |
Fetal non-stress test |
24 |
14 |
$2K |
| 83690 |
|
1,817 |
1,342 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
12 |
12 |
$2K |
| 82607 |
|
126 |
115 |
$2K |
| 87205 |
|
484 |
347 |
$2K |
| 94762 |
|
92 |
34 |
$2K |
| 83735 |
|
967 |
714 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
76 |
69 |
$1K |
| 86140 |
|
85 |
67 |
$1K |
| J3490 |
Unclassified drugs |
109 |
43 |
$1K |
| 83880 |
|
530 |
405 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,742 |
1,125 |
$1K |
| 85610 |
|
1,000 |
686 |
$1K |
| 74018 |
|
42 |
38 |
$990.58 |
| 87147 |
|
272 |
217 |
$962.64 |
| 84702 |
|
40 |
27 |
$835.74 |
| 80076 |
|
65 |
44 |
$775.71 |
| 82948 |
|
1,254 |
582 |
$741.29 |
| 85379 |
|
517 |
370 |
$719.90 |
| 76830 |
Ultrasound, transvaginal |
13 |
12 |
$714.13 |
| 87634 |
|
170 |
138 |
$685.42 |
| 83550 |
|
55 |
38 |
$679.32 |
| 97014 |
|
48 |
13 |
$675.12 |
| 99484 |
|
25 |
25 |
$623.23 |
| 83540 |
|
57 |
40 |
$615.04 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
15 |
14 |
$607.53 |
| 73610 |
|
82 |
67 |
$588.69 |
| 85652 |
|
123 |
95 |
$559.89 |
| 73630 |
|
90 |
82 |
$525.47 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
182 |
129 |
$479.18 |
| 99221 |
|
30 |
25 |
$475.96 |
| 73030 |
|
20 |
13 |
$418.90 |
| 82077 |
|
208 |
171 |
$418.07 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,431 |
938 |
$376.34 |
| 82043 |
|
59 |
55 |
$370.41 |
| 82728 |
|
19 |
12 |
$353.96 |
| 80055 |
|
15 |
12 |
$349.68 |
| 81025 |
|
1,130 |
780 |
$259.50 |
| 85730 |
|
233 |
167 |
$249.54 |
| 83605 |
|
327 |
230 |
$219.12 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
602 |
356 |
$211.44 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
27 |
15 |
$195.75 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,455 |
1,588 |
$194.79 |
| 80051 |
|
14 |
12 |
$191.63 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,562 |
924 |
$150.49 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
742 |
417 |
$119.80 |
| 87040 |
|
95 |
63 |
$109.83 |
| 86901 |
|
14 |
12 |
$97.09 |
| 84550 |
|
19 |
14 |
$94.48 |
| 86900 |
|
14 |
12 |
$80.64 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,103 |
687 |
$51.07 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
184 |
64 |
$45.61 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,037 |
1,251 |
$36.13 |
| J2704 |
Injection, propofol, 10 mg |
1,216 |
776 |
$34.20 |
| 85027 |
|
17 |
14 |
$31.46 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
828 |
543 |
$8.56 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
22 |
13 |
$3.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
243 |
108 |
$1.89 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
210 |
69 |
$1.75 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
27 |
15 |
$1.13 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
601 |
372 |
$0.95 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
170 |
96 |
$0.41 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
16 |
14 |
$0.38 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
257 |
185 |
$0.13 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
151 |
78 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
178 |
164 |
$0.00 |
| 74022 |
|
14 |
13 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
30 |
25 |
$0.00 |
| 94760 |
|
16 |
12 |
$0.00 |
| 96376 |
|
282 |
110 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
328 |
260 |
$0.00 |
| 87276 |
|
20 |
19 |
$0.00 |
| 64494 |
|
14 |
13 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
411 |
242 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,282 |
918 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61 |
53 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
39 |
$0.00 |
| 87275 |
|
20 |
19 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
78 |
42 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
15 |
14 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
12 |
12 |
$0.00 |